Biotech · Private company
DelMar Pharmaceuticals, Inc.
Track this companyFree. Adds DelMar Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Physician's Choice of Salvage Therapy - carboplatinPhase 3 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- Physician's Choice of Salvage Therapy - lomustinePhase 3 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- Physician's Choice of Salvage Therapy - temozolomidePhase 3 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- VAL-083, DianhydrogalactitolPhase 3 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- VAL-083, DianhydrogalactitolPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian CancerPHASE1_PHASE2 · WITHDRAWN · started Mar 1, 2021ClinicalTrials.gov NCT03281681 · fetched Nov 12, 2026
- VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMPHASE3 · TERMINATED · started Oct 27, 2017ClinicalTrials.gov NCT03149575 · fetched Nov 12, 2026